UFC’s Daniel Cormier in catbird’s seat as he waits for next foe to emerge
Daniel Cormier is resting in a comfortable spot as UFC light-heavyweight champion, as many men pursue his crown and he watches from a distance.
“Everything will work itself out … I’m going to wait and see, I’m easy,” Cormier told The Times on Thursday as he relaxed in Vancouver, Canada, and studied the fighters on Saturday’s “UFC Fight Night” on Fox.
“I don’t really care that much. They tell me when to show up, and I’ll be ready to go.”
Cormier (18-1) has been invested in his role as a Fox UFC analyst since defeating replacement opponent Anderson Silva at UFC 200 on July 9.
Silva was summoned after Cormier’s scheduled opponent, former long-reigning light-heavyweight champion Jon Jones, tested positive for a banned substance originally identified as the women’s fertility drug clomiphene.
Last week, information swirled around UFC 202 in Las Vegas that Jones actually tested positive for the erectile-dysfunction product Cialis after UFC President Dana White told talk-show host Jim Rome, “it’s looking like Jon Jones did not … take the drug that everybody thought he took. It looks like it’s something else.”
Cormier said UFC officials haven’t shared any detailed information with him, and Nevada State Athletic Commission Executive Officer Bob Bennett said a hearing on the Jones matter could come in September or October.
Even if Jones is cleared of taking a banned substance, he still faces possible discipline for not informing the U.S. Anti-Doping Agency that he was taking a medication, if indeed Cialis is the product.
“You do have to disclose everything,” Cormier said. “That is part of the deal. We are supposed to tell them everything we take, and if you don’t … I’m sure there will be some sort of punishment.”
That would imperil any chance of a Jones return in the Nov. 12 UFC debut in New York, Jones’ home state.
“I’m not sure I can fight in New York anyway,” Cormier said. “I have to make weight, get in camp, and I haven’t been able to train as much as I’d like because I’ve been so busy with TV. That would be tough.”
Although Anthony Johnson knocked out Glover Teixeira in 13 seconds Saturday to enhance his shot at Cormier, that’s not an automatic either, considering Jones’ situation and his possible reemergence for a Cormier rematch, which had been set to be the UFC 200 main event.
“We’re getting a little ahead of ourselves,” Cormier said.
In the meantime, Cormier is occupied with assessing the Saturday fights, beginning with the welterweight main event involving recent title challenger Carlos Condit and former middleweight title challenger Demian Maia, now the No. 3 welterweight.
Maia (23-6) has won five consecutive fights with two submissions.
“Maia is a guy who’s trying to fight for the belt again and shed the idea that he’s a guy that isn’t in an exciting fight,” Cormier said. “Now he’s finishing guys and is as close to a championship fight as he’s ever been. If Maia gets it to that grappling kind of fight, no one else can win that fight.”
Condit (30-9) participated in a fight-of-the-year contender in a January loss to Robbie Lawler.
“Although Condit is coming off a loss, because of the way he lost, it didn’t push him too far back in the division,” Cormier said. “If Condit can get Demian to move around, there’s no way Demian can out-strike Carlos.
“Hand to the fire, I pick Carlos. They’re both well-rounded, but they’re so good at what they do, if either gets [the fight] to their area, it’s over.”
Also on the card, former lightweight champion Anthony Pettis fights Charles Oliviera in a featherweight bout and No. 10 women’s straw-weight Paige VanZant returns from her runner-up showing on ABC’s “Dancing With the Stars” to meet Australia’s Bec Rawlings.
“Getting back in the win column, getting back in the UFC -- winning’s everything,” VanZant said.
Follow Lance Pugmire on Twitter @latimespugmire
More to Read
Go beyond the scoreboard
Get the latest on L.A.'s teams in the daily Sports Report newsletter.
You may occasionally receive promotional content from the Los Angeles Times.